Mrs Hannah Hollinger
Based at the Centre for Health Science in Inverness, I work as a Clinical Educator for NHS Highland and a Lecturer within the Department of Nursing and Midwifery for The University of Highlands and Islands.
I have worked within Neurosciences since 1997 and have 20 years nursing experience in a variety of fields ranging through, acute, rehabilitation, management, specialist and research nursing. I have specialized in the care management and research involving individuals with Motor Neurone Disease at a National level and continue to retain an interest in this area of care. I have been heavily involved in patient and public involvement initiatives and promote the involvement of patients throughout their care journey, and have been involved in developing educational resources to support them in managing their condition through evidence based methods.
My interests and experience are varied and extend into Health care law and ethics and Complementary therapies.
Co-applicant on Marie Curie Grant application to improve saliva management for people living with MND (funding confirmed 2017)
Gene expression signatures in motor neurone disease fibroblasts reveal dysregulation of metabolism, hypoxia-response and RNA processing functions. Raman R, Allen SP, Goodall EF, Kramer S, Ponger LL, Heath PR, Milo M, Hollinger HC, Walsh T, Highley JR, Olpin S, McDermott CJ, Shaw PJ, Kirby J. Neuropathol Appl Neurobiol. 2015 Feb;41(2):201-26.
The evidence for symptomatic treatments in amyotrophic lateral sclerosis. Jenkins TM, Hollinger H, McDermott CJ. Curr Opin Neurol. 2014 Oct; 27(5):524-31.
Lack of unique neuropathology in amyotrophic lateral sclerosis associated with p.K54E. angiogenin (ANG) mutation. J. Kirby, J. R. Highley, L. Cox, E. F. Goodall, C. Hewitt, J. A. Hartley, H. C. Hollinger, M. Fox, P. G. Ince, C. J. McDermott and P. J. Shaw (2013) Neuropathology and Applied Neurobiology 39, 562–571.
Lithium carbonate in patients with amyotrophic lateral sclerosis (LiCALS): a multicentre, randomised, double-blind, placebo-controlled trial. UKMND-LiCALS Study Group including H Hollinger. The Lancet Neurology, Volume 12, Issue 4, Pages 339 - 345, April 2013. Published Online: 27 February 2013.
Complementary therapies for people with motor neurone disease: extending a cancer care service. Philippa Hughes, Lynn Seymour, Hannah Hollinger, Jane Evans, Christopher McDermott and Pamela Shaw. BMJ Support Palliative Care 2012;2: A102-A103 doi:10.1136/bmjspcare-2012-000196.302.
Pattern of spread and prognosis in lower limb-onset ALS. Turner. M, Brockington. A, Scaber. J, Hollinger. H, Marsden. R, Shaw. P, Talbot. K. (ALS. 2010 August; 11(4): 369–373).
Evaluation of two different methods for per-oral gastrostomy tube placement in patients with Motor Neurone Disease (MND): PIG Versus PEG procedures. G Chavada*, A El-Nayal*, F Lee, SJ Webber, M McAlindon, T Walsh, H Hollinger, CJ McDermott, PJ Shaw. Amyotrophic Lateral Sclerosis 11:531-536, May 2010.
Mutations in CHMP2B in lower motor neuron predominant Amyotrophic Lateral Sclerosis (ALS). LE Cox, L Ferraiuolo, PR Heath, A Higginbottom, H Mortiboys, H Nixon, JA Hartley, A Brockington, CE Burness, SB Wharton, AJ Grierson, PG Ince, J Kirby, PJ Shaw. PloS One 5: e9872;2010 (ePub March 24).
Novel FUS/TLS mutations and pathology in familial and sporadic Amyotrophic Lateral Sclerosis. C. Hewitt, J. Kirby, J.R. Highley, J.A.Hartley, R. Hibberd, H. Hollinger, T.L.Williams, P.G. Ince, C.J. McDermott and P.J. Shaw. Archives of Neurology 2010,67(4):455-461.
Broad clinical phenotypes associated with TAR DNA binding protein (TARDBP) mutations in amyotrophic lateral sclerosis. J Kirby, E Goodall, W Smith, R Masanzu, JA Hartely, R Hibberd, HC Hollinger, SB Wharton, KE Morrison, PG Ince, CJ McDermott & PJ Shaw. Neurogenetics, DOI 10.1007/s10048-009-0218-9, 2010.
Large scale pathways based association study in amyotrophic lateral sclerosis. D Kasperavicute, ME Weale, KV Shianna, PF Sullivan, CL Simpson, VK Hansen, MR Turner, Al Chalabi, HS Pall, EF Goodall, KE Morrison, RW Orrell, M Bech, S Jabanka, M Sendtner, A Brockington, PG Ince, J Hartley, H Nixon, PJ Shaw, G Schiavo, NW Wood, DB Goldstein, EMC Fisher. Brain 130:2292-2301; 2007.
Mitochondrial DNA haplogroups and Amyotrophic Lateral Sclerosis. P Chinnery, C Mowbray, H Elliot, J Elson, H Nixon, J Hartley, P J Shaw. Neurogenetics 8:65-67; 2007.
Screening of the transcriptional regulatory regions of vascular endothelial growth factor receptor 2 (VEGFR2) in Amyotrophic Lateral Sclerosis. A Brockington, BWokke, H Nixon, J Hartley, P J Shaw. BMC Medical Genetics Apr 24;8 (1):23, 2007.
Mutations in VAPB are not associated with sporadic amyotrophic lateral sclerosis. J Kirby*, CAA Hewamadduma*, JA Hartley, HC Nixon, H Evans, RR Wadhwa, C Kershaw, PG Ince, PJ Shaw. Neurology 68:1951-1953; 2007.
Investigation of the mitochondrial genome in patients with atypical motor neuron disease. C Phoenix, GA Taylor, J Hartley, H Nixon, PG Ince, PJ Shaw, DM Turnbull, RW Taylor. J Neurol 254:482-487; 2007.
Complementary therapies for people with Motor Neurone Disease: extending a cancer care service’. 14-16 march 2012 Palliative care conference Gateshead.
Minimizing attrition in longitudinal MND studies: techniques used in a multi-centre, non-interventional study. Gibbons CJ, Addison-Jones R, Callagher P, Hollinger H, Johnson E, Marsden R. ALS Young Investigator's meeting in London 2010.
Fatigue in Motor Neurone Disease: its relationship with depression and anxiety. Gibbons CJ, Thornton EW, Talbot K, Mitchell JD, Ealing J, Hamdalla H, Shaw PJ, Young CA. Presented at Berlin Dec 2009 20th MND International Symposium. Provided data and support for this presentation.
The natural history of leg-onset ALS. Turner MR, Brockington A, Scaber J, Hollinger H, Marsden R, Shaw PJ, Talbot K. Presented at Berlin Dec 2009 20th MND International Symposium.
Rasch Validation of the Hospital Anxiety and Depression Scale in Motor Neurone Disease. Gibbons CJ, Mills RJ, Thornton EW, Talbot K, Mitchell JD, Ealing J, Hamdalla H, Shaw PJ,Tennant A, Pallant J, Young CA. Presented at Berlin Dec 2009 20th MND International Symposium. Provided data and support for this presentation.
Establishing biomarkers for distinct genetic and disease subtypes using gene expression profiling of fibroblasts from motor neuron disease (MND) patients. Janine Kirby, Shelley Kramer, Lize Linde Ponger, Rohini Raman, Paul R Heath, Laura Ferraiuolo, Alice Brockington, Rachel Hibberd, Hannah C Hollinger, Theresa Walsh, Christopher J McDermott & Pamela J Shaw. Presented at Berlin Dec 2009 20th MND International Symposium.
Gene expression profiling of blood of Primary Lateral Sclerosis patients to detect biomarkers and pathways involved in the disease process. Rohini Raman, Janine Kirby, Paul Heath, Rachael Hibberd, Hannah Hollinger, Christopher McDermott & Professor Pamela Shaw. Presented at Berlin Dec 2009 20th MND International Symposium.
Genetic screening of the NRF2 antioxidant pathway in Amyotrophic Lateral Sclerosis (ALS). Goodall. E, Smith. W, Kirkby. J, Hartley. J, Nixon. H, Wood-Allum. C, Shaw. P. Presented at the Birmingham Dec 2008 19th International Symposium.
The ‘Flail Leg’ Variant of Amyotrophic Lateral Sclerosis. Brockington. A, Nixon. H, Highley. R, Wharton. S, Shaw. PJ. Presented at the Toronto Dec 2007 18th International Symposium.
Evaluation of the Natural History of Non-Invasive Ventilation (NIV) support for patients with Motor Neurone Disease (MND). Ms Hannah Nixon, Dr Catherine Billings, Mrs Alison Proctor, Dr Edward Moloney, Ms Theresa Walsh, Professor Pamela Shaw. Presented at the Japan Dec 2006 17th MND International Symposium.
Screening for potential candidate genes and risk factors in a large cohort of MND cases: Assessing the contribution of ANG, CHMP2B and HFE. Cox. L, Kirkby. J, Namavar. Y, Hartley. J, Nixon. H, Ince. P, Shaw. P. Presented at the Japan Dec 2006 17th MND International Symposium.
Study to develop criteria for successful provision of mobile arm supports (MAS) for people with Motor Neurone Disease (PWMND). German. VO, Walsh. T, Nixon. HC. Presented at the Philadelphia 2004 15th MND International Symposium.
- BSc (Hons) in Nursing at Leeds
- ENB 148 – Advanced Neurosciences Nursing (level 2)
- ENB 998 – Teaching and assessing in clinical practice (level 2)
- Masters in Health Care Law and Ethics at Manchester University
Nursing and Midwifery Council (NMC)
Clinical Lecturer for University of Highlands and Islands
- Qualified Bowen Therapist
- Motor Neurone Disease
- Clinical Education
- Leadership and Management